准2基酶以增强三桑丁在HeLa和SCC25细胞模型中的抗癌效果
Yan Zhou1, Maoxin Ran1, Wenying Shan1
1Faculty of Health Sciences, University of Macau, Taipa, Macau.
ADMET & DMPK
|December 23, 2024
概括
将三桑丁 (TCS) 与素 (Benz) 结合起来,这是一种素激酶2 (HK2) 抑制剂,通过准糖解,显示出协同作用的抗癌效应. 这种组合抑制了瘤生长,并为癌症治疗提供了一个有前途的策略.
科学领域:
- 在瘤学瘤学.
- 生物化学 生化学
- 分子生物学分子生物学
背景情况:
- 三桑丁 (TCS) 是一种具有抗癌潜力的植物衍生的核糖体失活蛋白.
- 由于TCS的抗原性,其临床应用受到限制.
- 基酶2 (HK2) 在癌症糖解中至关重要,也是潜在的治疗点.
研究的目的:
- 为了研究TCS和HK2抑制剂本塞拉 (Benz) 的联合抗癌作用.
- 在Hela和SCC25癌症模型中阐明组合治疗的潜在机制.
- 为了评估TCS-Benz组合的体内疗效.
主要方法:
- 用MTT,殖民地形成和细胞周期试验来评估细胞毒性.
- 糖解调节,亡和信号通路通过海马试验,西部涂抹和流动细胞计分析.
- 在SCC25细胞异种移植小鼠模型中评估了体内疗效.
主要成果:
- 在Hela和SCC25细胞中,TCS-Benz组合显示出协同作用的抗癌作用.
- 该组合调节了糖解,减少了乳酸盐和增加了ROS,抑制了增殖和诱导了亡.
- 在异种移植小鼠模型中,瘤生长被显著抑制.
结论:
- 准HK2和调节糖解可以提高TCS在癌症治疗中的疗效.
- 通过抑制关键癌症途径,TCS-Benz组合是一种有前途的治疗策略.
- 这种方法可以克服TCS抗原性限制并改善临床结果.
相关概念视频
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
02:34Inhibition of Cdk Activity
4.6K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.6K